Polymeric nano-particles for siRNA delivery using charge interaction and covalent bonding

Phosphodiesterase 4D7 as prostate cancer marker

Use of the GTPase Rab27B to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer

Lipids, lipid complexes and use thereof

Novel Target for Regulating Multiple Sclerosis

Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor

Inhibition of MAP4K4 through RNAI

RNAi expression constructs

Adenoviral VA1 Pol III expression system for RNAi expression

Lipids and compositions for the delivery of therapeutics

NEUROPILIN-1 INHIBITORS

METHODS AND USES INVOLVING GENETIC ABERRATIONS OF NAV3 AND ABERRANT EXPRESSION OF MULTIPLE GENES

METHOD OF TREATMENT OF VASCULAR COMPLICATIONS

PROCESS FOR THE PREPARATION OF A COMPOSITION OF GENETICALLY MODIFIED HEMATOPOIETIC PROGENITOR CELLS

Prevention and treatment of disease in bees

Treatment of neurological disorders by dsRNA administration

Regulation of MIR-33 MicroRNAs in the Treatment of Cholesterol-Related Disorders

Oligonucleotide analogs as therapeutic agents

METHODS AND COMPOSITIONS RELATED TO THE REGULATION OF GOBLET CELL DIFFERENTIATION, MUCUS PRODUCTION AND MUCUS SECRETION

METHODS AND COMPOSITIONS FOR SELECTING SIRNA OF IMPROVED FUNCTIONALITY

USES OF MAMMALIAN CYTOKINE; RELATED REAGENTS

Compositions, kits, and methods for making induced pluripotent stem cells using synthetic modified RNAs

Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1

Multi-targeting short interfering RNAs

FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases

Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles

gene from the potato cyst nematode

JARID1B FOR TARGET GENE OF CANCER THERAPY AND DIAGNOSIS

Compositions and Methods for Inducing an Immune Response in a Mammal and Methods of Avoiding an Immune Response to Oligonucleotide Agents Such as Short Interfering RNAs

Methods for Treating Autophagy-Related Disorders

Composition and Methods for the Diagnosis and Treatment of Tumor

RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Delivery of dsRNA to arthropods

Compositions And Methods For Inhibiting Expression Of MIG-12 Gene

DESIGN OF SMALL-INTERFERING RNA

ISOLATION OF FACTORS THAT ASSOCIATE DIRECTLY OR INDIRECTLY WITH CHROMATIN

Ribonucleic acid interference molecules

Reduced size self-delivering RNAi compounds

TREATMENT OF RADIATION-INDUCED FIBROSIS

COMPOSITIONS AND METHODS FOR SIRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2

Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor

Method for inhibiting the activity of mir-155

RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton

METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION

PARP1 TARGETED THERAPY

PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY OR DIABETES

USE OF INHIBITORS OF PLAC8 ACTIVITY FOR THE MODULATION OF ADIPOGENESIS

Conserved HBV and HCV sequences useful for gene silencing

Chemical modifications of monomers and oligonucleotides with cycloaddition

Aptamer regulated nucleic acids and uses thereof

Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker

HIV-RESISTANT STEM CELLS AND USES THEREOF

MEANS AND METHODS FOR DURABLE INHIBITION OF PATHOGENS

Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer

Methods and compositions for root knot nematode control

RNA sequence-specific mediators of RNA interference

Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome

RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)

Short interfering ribonucleic acid (siRNA) for oral administration

Short interfering ribonucleic acid (siRNA) for oral administration

siRNA targeting VEGFA and methods for treatment in vivo

Inhibiting serum response factor (SRF) to improve glycemic control

MULTIPLE RNA POLYMERASE III PROMOTER EXPRESSION CONSTRUCTS

Polypeptides having arabinofuranosidase activity and polynucleotides encoding same

METHODS AND COMPOSITIONS RELATING TO POLYPEPTIDES WITH RNASE III DOMAINS THAT MEDIATE RNA INTERFERENCE

RAD9 AS A DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC TOOL FOR PROSTATE CANCER

Biodegradable lipids for the delivery of active agents

Lipids and compositions for the delivery of therapeutics

Methods and means for treatment of osteoarthritis

Signal activated molecular delivery

RNA Interference Mediated Inhibition of the Thymic Stromal Lymphopoietin (TSLP) Gene Expression Using Short Interfering Nucliec Acid (siNA)

RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 1 (STAT1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Compositions and methods for inhibiting expression of a gene from the JC virus

Short interfering ribonucleic acid (siRNA) for oral administration

Means for inhibiting the expression of ANG2

METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS

Compositions and methods for inhibiting expression of mutant EGFR gene

BREAST CANCER RELATED GENE RQCD1

PKIB and NAALADL2 for Target Genes of Prostate Cancer Therapy and Diagnosis

Sustained release siRNA for ocular drug delivery

Cancer antigen eEF2

Structurally designed shRNAs

Diagnosis and treatment of cancer

MHC-less cells

RNAi molecule targeting thymidylate synthase and application thereof

RNA Interference Mediated Inhibition of Connective Tissue Growth Factor (CTGF) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA Interference Mediated Inhibition of BTB and CNC Homology 1, Basic Leucine Zipper Transcription Factor 1 (BACH1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene

SMALL INTERFERENCE RNA COMPLEX WITH INCREASED INTRACELLULAR TRANSMISSION CAPACITY

Compositions And Methods For Increasing Cellular Uptake Of RNAi Via SID-1

Phagocytic cell delivery of RNAI

siRNA targeting Superoxide

Enigma-Mdm2 interaction and uses thereof

RNA sequence-specific mediators of RNA interference

Methods of treating thyroid eye disease

Adenylyl cyclase-associated protein (CAP1) and uses thereof as a target for immuno-modulation

Therapeutic Compositions for Treatment of Corneal Disorders

ALPHA SYNUCLEIN TOXICITY

Regulators of the Interferon-Alpha Receptor 1 (IFNAR1) Chain of the Interferon Receptor

Nucleic acid aptamers

RNA Interference Mediated Inhibition of Apoptosis Signal-Regulating Kinase 1 (ASK1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Single-stranded nucleic acid molecule for controlling gene expression

RNAi MODULATION OF MLL-AF4 AND USES THEREOF

TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER

SiRNA targeting myeloid differentiation primary response gene (88) (MYD88)

Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity

Viral Therapy and Prophylaxis Using Nanotechnology Delivery Techniques

RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

ANNEXIN A11 AND ASSOCIATED GENES AS BIOMARKERS FOR CANCER

ShRNA gene therapy for treatment of ischemic heart disease

RNA Interference Mediated Inhibition of the Intercellular Adhesion Molecule 1 (ICAM-1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA Interference Mediated Inhibition of the Nerve Growth Factor Beta Chain (NGFB) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA interference mediated inhibition of the FCεR1α gene

Compositions and methods for modulating activity of capped small RNAS

VECTOR(S) CONTAINING AN INDUCIBLE GENE ENCODING A CDK4/CDK6 INHIBITOR USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS OR DISEASES ASSOCIATED WITH AN UNSCHEDULED ACTIVATION OF THE CELL CYCLE

Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2

Targeted delivery system

METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION

Single walled carbon nanotube/sirna complexes and methods related thereto

Compositions and Methods for the Treatment of Ophthalmic Disease

Compositions and Methods to Treat Bone Related Disorders

Methods used in identifying glioblastoma

METHODS FOR TREATING NEOPLASIA BY INHIBITING LACTATE DEHYDROGENASE AND/OR NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

siRNA targeting cyclin-dependent kinase 4 (CDK4)

Cell-specifically effective molecules on the basis of siRNA and application kits for the production thereof and use thereof

TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRT1

siRNA targeting gremlin

SiRNA targeting histamine receptor H1

Method for enhancing a function of a T cell

Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy

Anticancer drug comprising inhibitor of TMPRSS4

Method to trigger RNA interference

METHODS AND SUBSTANCES FOR STIMULATING MUSCLE REGENERATION

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

RNA INTERFERENCE MEDIATED INHIBITION OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNAi modulation of RSV and therapeutic uses thereof

UNA oligomer structures for therapeutic agents

Oligomeric compounds and methods

RNAI BASED SELECTION SYSTEM

Lipids and compositions for the delivery of therapeutics

Lipids and compositions for the delivery of therapeutics

Sp35 Antibodies and Uses Thereof

Antibodies that bind polypeptides involved in the process of bone remodeling

Platelet derived growth factor receptor supports cytomegalovirus infectivity

IMPLANT COATING WITH NUCLEIC ACIDS

METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION

STABILIZATION METHOD OF FUNCTIONAL NUCLEIC ACID

RNA interference mediating small RNA molecules

COMPOSITIONS AND METHODS FOR EX VIVO HEPATIC NUCLEIC ACID DELIVERY

Methods for expansion of hematopoietic stem and progenitor cells

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

PROLIFERATION-ASSOCIATED MODULATION OF THE SPLICING OF THE INTEGRIN ALPHA 6 ISOFORMS

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

Compositions and methods for insecticidal control of stinkbugs

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

NECTIN-4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS

NUCLEIC ACID DRUG FOR TREATMENT OF ALLERGIC DISEASE

TREATMENT OF AIRWAY HYPERREACTIVITY

COMPOSITIONS AND METHODS FOR COMBINED THERAPY OF DISEASE

COLON CANCER TARGETS AND USES THEREOF

LIPIDS, LIPID COMPLEXES AND USE THEREOF

TREATMENT OF TUMOR SUPPRESSOR GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO THE GENE

Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference

MODULATION OF TRANSTHYRETIN EXPRESSION

Sensizitation of cancer cells to therapy using sina targeting genes from the 1P and 19Q chromosomal regions

Pharmaceutical composition for treating dementia comprising ShRNA inhibiting S100a9 expression

Expression system

Methods for diagnosing or treating prostate cancer

Methods and compositions for localized agent delivery

Aminoalcohol lipidoids and uses thereof

Reagents and methods for treating cancer

ANTAGONISTS OF MIR-155 FOR THE TREATMENT OF INFLAMMATORY LIVER DISEASE

COMPOSITION AND METHODS FOR MODULATING TOLL-LIKE RECEPTOR ACTIVITY

Pain treatment using ERK2 inhibitors

INHIBITION OF VEGF-A SECRETION, ANGIOGENESIS AND/OR NEOANGIOGENESIS BY SINA MEDIATED KNOCKDOWN OF VEGF-C AND RHOA

RNA sequence-specific mediators of RNA interference

METHOD OF INHIBITING GENE EXPRESSION

Treatment of metabolic-related disorders using hypothalamic gene transfer of BDNF and compositions therefor

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

SIRNA COMPOUNDS AND METHODS OF USE THEREOF

RNA Interference Mediated Inhibition of Epithelial Sodium Channel (ENaC) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop

NUCLEIC ACID DELIVERY COMPOSITIONS AND METHODS

Simplified method for partial genetic and epigenetic reprogramming of cells using siRNA specific for a heterochromatin protein 1

Compositions and methods for inhibiting expression of a mutant gene

MODULATION OF OLFML-3 MEDIATED ANGIOGENESIS

Agents and methods to elicit anti-tumor immune response

THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS

Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes

CHEMOSENSITIZATION BY BI-FUNCTIONAL SMALL HAIRPIN RNA (bi-shRNA)

Multiblock copolymers

NOVEL HUMAN ENDOGENOUS RETROVIRAL ERV3 VARIANT AND USES THEREOF IN THE DIAGNOSING OVARIAN CANCER

Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof

METHODS OF TREATING COGNITIVE DISORDERS BY INHIBITION OF GPR12

RNA sequence-specific mediators of RNA interference

SiRNA targeting beta secretase (BACE)

Production of acid and solvent in microorganisms

Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis C virus

siRNA of NF-kB p105 for inhibiting cell proliferation and migration and a composition comprising same

METHOD FOR MIR-125A IN PROMOTING HEMATOPOIETIC STEM CELL SELF RENEWAL AND EXPANSION

REGULATION OF CYCLIN D

Methods and compositions related to targeting monoacylglycerol lipase

METHOD OF INHIBITING PROLIFERATION OF HEPATIC STELLATE CELLS

Method for polymerizing a small oligonucleotide, and use of a high-molecular oligonucleotide prepared by the polymerization method

Composition for improving inflammatory disease using ABH antigens

Detection and treatment of non-dermal fibrosis

COLON DISEASE TARGETS AND USES THEREOF

siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

Compositions and methods for inhibiting expression of the HAMP gene

RNAi-mediated inhibition of histamine receptor H1-related conditions

Inhibition of viral gene expression using small interfering RNA

Gene Silencing by Single-Stranded Polynucleotides

TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-ALPHA2

NURR-1 Interacting Protein (NuIP)

CCR3 inhibition for ocular angiogenesis and macular degeneration

ANTIBODIES AND PROCESSES FOR PREPARING THE SAME

Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Organic compositions to treat beta-ENaC-related diseases

Reduced size self-delivering RNAi compounds

Small interfering RNA for gene knockdown of the subcutaneous N-methyl-D-aspartate receptor NR1 subunit, and it's application on pharmaceutics

Construction of protein-responsive shRNA/RNAi control system using RNP motif

STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES

SYNGR4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS

TREATMENT OF PROLIFERATIVE DISORDERS WITH A DEATH RECEPTOR AGONIST

TREATING CANCER BY MODULATING RNA HELICASES

THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF

Molecular marker for cancer stem cell

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

INCREASING EFFICIENCY OF NUCLEIC ACID DELIVERY IN VIVO USING TARGETING CONJUGATES

RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis

Method of Treating Neurodegenerative Disease

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND SMALL MOLECULES FOR USE IN REDUCING MICRO RNA ACTIVITY LEVELS AND USES THEREOF

Transferrin/transferrin receptor-mediated siRNA delivery

Modulation of axon degeneration

Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications Thereof

RNAi Modulation of the BCR-ABL Fusion Gene and Uses Thereof

Compositions and methods for inhibiting expression of an RNA from West Nile virus

NOVEL siRNAS AND METHODS OF USE THEREOF

Compositions and methods for inhibiting expression of CD274/PD-L1 gene

RNAI CONSTRUCTS AND USES THEREOF

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

Use of TRIM72 as a target for muscle and heart enhancer

PANCREATIC CANCER RELATED GENE TTLL4

COMPOSITIONS AND METHODS FOR ENHANCING CELLULAR TRANSPORT OF BIOMOLECULES

Virus-Like Particle Mediated Cellular Delivery

USE OF ULTRACONSERVED RNA IN DETECTION AND TREATMENT OF CANCER

Method for selecting SIRNAs from a plurality of SIRNAs for gene silencing

Method for screening cancer therapeutic agent using galectin-3, GSK-3β, and fascin-1

INHIBITION OF BRAIN ENZYMES INOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION

Methods and compositions for diagnosing and treating diseases

Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease

DOUBLE-STRANDED RNA STRUCTURES AND CONSTRUCTS, AND METHODS FOR GENERATING AND USING THE SAME

Pharmaceutical composition for treatment of cancer and asthma

Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator

Nuclease resistant double-stranded ribonucleic acid

RNAi-mediated inhibition of Rho kinase for treatment of ocular disorders

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA interference suppression of neurodegenerative diseases and methods of use thereof

SiRNA-mediated gene silencing

ApoIII and the treatment and diagnosis of diabetes

RNA sequence-specific mediators of RNA interference

INHIBITING OBESITY PROGRESSION BY INHIBITING ADIPOCYTE DIFFERENTIATION WITH A PRE-ADIPOCYTE AUTOPHAGY INHIBITOR

Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

MATERIALS AND METHODS FOR PREVENTING OR TREATING NEURODEGENERATIVE CONDITIONS ASSOCIATED WITH ABETA PEPTIDE ACCUMULATION

METHODS OF INHIBITING TUMOR GROWTH USING BETA 5 INTEGRIN ANTAGONISTS

Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands

RNA INTERFERENCE TARGET FOR TREATING AIDS

Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein

METHODS OF TREATING HEPATITIS C VIRUS INFECTION

Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof

Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells

RNA VECTOR THERAPY METHOD

Detection and destruction of cancer cells using programmed genetic vectors

Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF

RNA interference in skin indications

Inhibitory RNA for modulating the molecular function of ZFAT gene

Use of RNAi technology to inhibit ASIC3

Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity

Neutral nanotransporters

Method for treating or preventing bladder cancer using the DEPDC1 polypeptide

NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF

MULTICISTRONIC siRNA CONSTRUCTS TO INHIBIT TUMORS

Antagonists of NR2F6 For Augmenting The Immune Response

Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy

LIMITED PROTEOLYSIS OF CD2AP AND PROGRESSION OF RENAL DISEASE

METHODS FOR THE REGULATION OF THE PROSTAGLANDIN F SYNTHASE (PGFS) ACTIVITY OF AKR1B1 AND USES THEREOF

MULTICISTRONIC VECTORS AND METHODS FOR THEIR DESIGN

dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION

EML4-ALK fusion gene

Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer

Compositions and methods for inhibiting expression of the PCSK9 gene

Compositions for protection and cellular delivery of interfering RNA

Low density lipoprotein receptor-mediated siRNA delivery